Novo Pakistan Steps Up Efforts to Support Insulin Access

Novo Pakistan is strengthening its efforts to support people living with diabetes amid concerns about insulin access. The company is working closely with its partners to help maintain treatment continuity, recognising the importance of a reliable insulin supply for patients and their families.

Pakistan has an estimated 33 million people living with diabetes, while more than one million rely on insulin. In response to this challenge, Novo Pakistan says it is pursuing practical, long-term solutions to help address the country’s growing diabetes burden.

Mehtaz Sultan Khan, General Manager of Novo Pakistan, reaffirmed the company’s commitment to diabetes care.

Pakistan to Host First-Ever PUBG MOBILE Global Open Esports Event in Lahore

“Diabetes care has been at the heart of Novo for more than 100 years, and delivering on that commitment remains our priority today. For people who depend on insulin, reliable access to treatment is essential. We recognise the concerns being raised and are stepping up to play our part in supporting patients in Pakistan,” Khan said.

The company emphasised the importance of dependable treatment access for people living with diabetes. Its ongoing engagement with partners aims to support continuity of care as Pakistan faces the significant public health challenge posed by diabetes.